{"id":"W2138727105","doi":"10.1191/1078155201jp077oa","title":"Zoledronic acid versus pamidronate as palliative therapy in cancer patients: A Canadian time and motion analysis","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada); Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Novartis Pharmaceuticals Canada","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Palliative care; Cancer; Outpatient clinic; Internal medicine; Osteoporosis; Nursing","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002803032,0.001065044,0.001478156,0.002908631,0.001276611,0.001756146,0.002033272,0.0007351983,0.00610219],"category_scores_gemma":[0.009156786,0.0005053084,0.003802328,0.005995386,0.0004842431,0.0004804664,0.0007726479,0.001005789,0.0002453091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06261158,"about_ca_system_score_gemma":0.04972162,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9876359,"about_ca_topic_score_gemma":0.9849001,"domain_scores_codex":[0.9977567,0.0005643346,0.00008277026,0.0001913701,0.0008560286,0.0005488786],"domain_scores_gemma":[0.9946954,0.002022733,0.0004521344,0.0001135681,0.002281765,0.0004344352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.01410982,0.001022778,0.2379702,0.003724111,0.006013159,0.0008728489,0.0006393236,0.5140342,0.001550649,0.02219177,0.06611648,0.1317546],"study_design_scores_gemma":[0.003316467,0.002013794,0.3762256,0.00063118,0.008231036,0.0004226822,0.001694516,0.5621061,0.0008723871,0.002817304,0.04125566,0.0004131779],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.903763,0.01646109,0.004147771,0.004813933,0.0001535723,0.001367755,0.03008264,0.0001752693,0.03903501],"genre_scores_gemma":[0.9757878,0.005089398,0.003420088,0.0005675558,0.00004089353,0.0002056847,0.009026829,0.00007051497,0.005791134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06261158,"threshold_uncertainty_score":0.4542809,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05877844720783541,"score_gpt":0.4506040074454726,"score_spread":0.3918255602376372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}